ConductScience.org, home

Paper · 37726283

References254

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134794169Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.Nature2022https://conductscience.org/library/papers/34794169PubMed
232728218An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.Nature2020https://conductscience.org/library/papers/32728218PubMed
332591862
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
Cancer Immunol Immunother2020https://conductscience.org/library/papers/32591862PubMed
416947019T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.Cancer Immunol Immunother2007https://conductscience.org/library/papers/16947019PubMed
530518847Structural and molecular mechanisms for the control of eukaryotic 5'-3' mRNA decay.Nat Struct Mol Biol2018https://conductscience.org/library/papers/30518847PubMed
629456015Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.Vaccine2018https://conductscience.org/library/papers/29456015PubMed
733685460Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.Mol Cancer2021https://conductscience.org/library/papers/33685460PubMed
88760800Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.J Exp Med1996https://conductscience.org/library/papers/8760800PubMed
932153780Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.Clin Transl Immunology2020https://conductscience.org/library/papers/32153780PubMed
1023921513A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23921513PubMed
1125263094The ReNAissanCe of mRNA-based cancer therapy.Expert Rev Vaccines2015https://conductscience.org/library/papers/25263094PubMed
1229567706Personalized vaccines for cancer immunotherapy.Science2018https://conductscience.org/library/papers/29567706PubMed
1335339668Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.Semin Cancer Biol2022https://conductscience.org/library/papers/35339668PubMed
1430803823mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.Mol Ther2019https://conductscience.org/library/papers/30803823PubMed
1526321183mRNA: Fulfilling the Promise of Gene Therapy.Mol Ther2015https://conductscience.org/library/papers/26321183PubMed
1630504800Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing.Sci Rep2018https://conductscience.org/library/papers/30504800PubMed
1718797453Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.Mol Ther2008https://conductscience.org/library/papers/18797453PubMed
1828527533Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.J Am Coll Cardiol2017https://conductscience.org/library/papers/28527533PubMed
1935264324Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.BMJ2022https://conductscience.org/library/papers/35264324PubMed
208903508The eIF-2alpha kinases and the control of protein synthesis.FASEB J1996https://conductscience.org/library/papers/8903508PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/37726283/references